Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIDEROS open-label extension of idebenone in Duchenne muscular dystrophy
MOH_2020-03-18_008738Phase 3Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Started Feb 2020; status: completed.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on MOH_2020-03-18_008738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-03-18_008738.